Reuters news agency reported on Friday that the government of Argentina has said it received 904,000 doses of Chinese pharmaceutical company Sinopharm's COVID-19 vaccine in its first delivery on 25 February 2021.
Reportedly, this delivery, part of a deal for one million doses of the COVID-19 vaccine, arrived on a plane of Argentina's state carrier from Beijing late in the evening.
According to Argentina's government, the remaining 96,000 remaining doses of the agreement with Sinopharm will arrive in the next few days.
The Foreign Minister of Argentina, Felipe Sola, tweeted: "Everyone is going to get their vaccine and Argentina will be able to move forward."
Reportedly, the Sinopharm COVID-19 vaccines received will add to the 1.22 million doses of Russia's Sputnik V COVID-19 vaccines Argentina has already received, as well as to the 580,000 doses of Covishield, manufactured by the Indian Serum Institute in conjunction with AstraZeneca and Oxford University.
So far, Argentina has recorded over two million cases of COVID-19, with nearly 52,000 deaths.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses